BARIVA:Short Versus Extended Prophylaxis of Rivaroxaban for Venous Thromboembolism After Bariatric Surgery
Phase of Trial: Phase II
Latest Information Update: 31 Oct 2019
Price : $35 *
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Venous thromboembolism
- Focus Therapeutic Use
- Acronyms BARIVA
- 02 Oct 2019 Planned End Date changed from 1 Dec 2019 to 31 Dec 2021.
- 02 Oct 2019 Planned primary completion date changed from 1 Nov 2019 to 31 Dec 2021.
- 24 Jul 2018 Status changed from not yet recruiting to recruiting.